Titan Biotech Ltd - 524717 - Board Meeting Outcome for Outcome Of Board Meeting Dated September 3, 2026BSE filing · raw filing ↗
31 Aug 2026
⚑ Filing
Titan Biotech Ltd - 524717 - Board Meeting Intimation for Considering Bonus Issue, Draft AGM Notice, Draft Directors Report, Fix AGM, Decide Cut Off Date, E-Voting Dates, Record Dates, Books Closure And Any Other Items With The Permission Of Chair.BSE filing · raw filing ↗
31 Aug 2026
⚑ Filing
Titan Biotech Ltd - 524717 - Closure of Trading WindowBSE filing · raw filing ↗
14 Aug 2026
⚑ Filing
Titan Biotech Ltd - 524717 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
13 Aug 2026
⚑ Filing
Titan Biotech Ltd - 524717 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2026BSE filing · raw filing ↗
13 Aug 2026
⚑ Result
Q1 FY27 results filed — revenue ₹59 Cr (+27.2% YoY), PAT ₹11 Cr (+58.2% YoY)BSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first